Interojo Co Ltd
KOSDAQ:119610
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
24 900
34 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Interojo Co Ltd
Cash & Cash Equivalents
Interojo Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Cash & Cash Equivalents
₩10.4B
|
CAGR 3-Years
12%
|
CAGR 5-Years
6%
|
CAGR 10-Years
13%
|
|
|
SD Biosensor Inc
KRX:137310
|
Cash & Cash Equivalents
₩482.4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Cash & Cash Equivalents
₩46B
|
CAGR 3-Years
42%
|
CAGR 5-Years
68%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Cash & Cash Equivalents
₩89.7B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
11%
|
CAGR 10-Years
45%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Cash & Cash Equivalents
₩19.3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
|
H
|
Humasis Co Ltd
KOSDAQ:205470
|
Cash & Cash Equivalents
₩11.6B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
Interojo Co Ltd
Glance View
INTEROJO, Inc. engages in the manufacture and sale of contact lenses. The company is headquartered in Pyeongtaek, Gyeonggi-Do. The company went IPO on 2010-07-28. The Company’s products include silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, rigid gas permeable (RGP) contact lenses and solutions. The firm distributes its products in domestic and overseas markets.
See Also
What is Interojo Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
10.4B
KRW
Based on the financial report for Sep 30, 2024, Interojo Co Ltd's Cash & Cash Equivalents amounts to 10.4B KRW.
What is Interojo Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
13%
Over the last year, the Cash & Cash Equivalents growth was 344%. The average annual Cash & Cash Equivalents growth rates for Interojo Co Ltd have been 12% over the past three years , 6% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
